Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Medicinas Complementárias
Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Gynecol Obstet Invest ; 70(3): 154-9, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20558988

RESUMEN

AIMS: To characterize the reproductive health of urban South Korean women of reproductive age. METHODS: A cross-sectional online survey on menstrual patterns, sexual behavior, utilization of contraception, and perception of gynecological diseases was administered to 500 women from 15 to 39 years of age in five major cities of South Korea. RESULTS: Among the respondents, 76.8 and 25% experienced dysmenorrhea and abnormal uterine bleeding, respectively. Two-thirds of the respondents with dysmenorrhea used analgesics. After analgesics, herbal medicine was the next most commonly used treatment. The mean age of first sexual intercourse was 24.3 years, and 68.8% of the sexually active women used contraception. The most commonly used contraceptive method was the condom (79.7%), and many women (up to 62.2%) demonstrated a distorted understanding of oral contraceptives. Although many women were aware of general gynecological diseases such as cervical cancer (77%), endometriosis (64.4%), and leiomyoma (62.6%), only 22.2% of the respondents had visited a clinic for a gynecological examination, and among those who had visited a clinic, the main reason for the visit was pregnancy (44.1%). CONCLUSION: The results of this survey provide insight into and allow us to characterize the reproductive health status of urban South Korean women.


Asunto(s)
Conducta Anticonceptiva/estadística & datos numéricos , Conocimientos, Actitudes y Práctica en Salud , Conducta Sexual/estadística & datos numéricos , Población Urbana/estadística & datos numéricos , Adolescente , Adulto , Estudios Transversales , Femenino , Enfermedades de los Genitales Femeninos/psicología , Humanos , Menstruación , Historia Reproductiva , República de Corea , Encuestas y Cuestionarios , Adulto Joven
2.
Fertil Steril ; 91(3): 744-8, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-18321491

RESUMEN

OBJECTIVE: To explain the unexpected low response to GnRH antagonist protocol in reproductive women with normal baseline hormone profiles. DESIGN: Retrospective study. SETTING: University hospital. PATIENT(S): Twenty-five women undergoing their first IVF cycle. INTERVENTION(S): Follicular fluid (FF) from large follicles (>15 mm) was obtained during oocyte retrieval from unexpected low responders (n = 13, group A) and 12 age-matched normal responders (n = 12, group B). MAIN OUTCOME MEASURE(S): The FF markers known to reflect follicle environment (insulin-like growth factor [IGF] II, IGF-binding protein 4, müllerian-inhibiting substance, pregnancy-associated plasma protein A, soluble Fas, and vascular endothelial growth factor [VEGF]) were analyzed by ELISA. RESULT(S): The baseline characteristics (age, day 3 serum LH, FSH, E(2), duration and dose of r-FSH, GnRH antagonist) were not different between the two groups. The number of large follicles, oocytes retrieved, and serum E(2) levels on the day of hCG injection were significantly higher in group B. Whereas the other follicular markers did not differ between the two groups, VEGF was significantly higher in group A. In addition, the VEGF concentration showed an inverse correlation with the total number of oocytes retrieved. CONCLUSION(S): The unexpected low response in women with normal basal hormone profiles, during GnRH antagonist protocol, was associated with altered follicular VEGF expression.


Asunto(s)
Fármacos para la Fertilidad Femenina/administración & dosificación , Fertilización In Vitro , Líquido Folicular/metabolismo , Hormona Liberadora de Gonadotropina/antagonistas & inhibidores , Antagonistas de Hormonas/administración & dosificación , Hormonas/sangre , Inducción de la Ovulación/métodos , Factor A de Crecimiento Endotelial Vascular/metabolismo , Adulto , Gonadotropina Coriónica/administración & dosificación , Estradiol/sangre , Femenino , Hormona Folículo Estimulante Humana/administración & dosificación , Hormona Folículo Estimulante Humana/sangre , Hormona Liberadora de Gonadotropina/administración & dosificación , Hormona Liberadora de Gonadotropina/análogos & derivados , Humanos , Hormona Luteinizante/sangre , Recuperación del Oocito , Pancuronio/administración & dosificación , Pancuronio/análogos & derivados , Embarazo , Índice de Embarazo , Progesterona/sangre , Estudios Retrospectivos , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA